Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Abdominal Perfusion Pressure in Septic Shock
NCT05358912Phase 4Completed
- Sponsor
- Bozyaka Training and Research Hospital
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Bozyaka Training and Research Hospital. Primary endpoints: Change of the Level of Acute Kidney Injury up to 90 days, Mortality at 30th day at 30 days and 1 more. Started Dec 2019; status: completed.
Beyond the preview
Go deeper on NCT05358912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05358912.